Perphenazine Market is forecast to 100 million US By 2025

This report studies the global market size of Perphenazine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Perphenazine in these regions.
This research report categorizes the global Perphenazine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.

Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.

North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

In 2017, the global Perphenazine market size was 95 million US$ and is forecast to 100 million US in 2025, growing at a CAGR of 0.6% from 2018. The objectives of this study are to define, segment, and project the size of the Perphenazine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Perphenazine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Perphenazine include

Teva

Sandoz

Endo

Mylan

ZHPHARMA

Shandong Boshan Pharma

Market Size Split by Type

Oral Forms

Injectable Solution

Market Size Split by Application

Psychosis

Antiemetic

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/742077/global-perphenazine-market

Market size split by Region
North America
Asia-Pacific
Europe
Central & South America
Middle East & Africa

Buy Full Perphenazine Market Report Now, Report delivery time within 24 hours https://www.qyresearch.com/settlement/pre/9a8e7284fcfeb9352de1c740b3ddbcea,0,1,Global%20Perphenazine%20Market%20Insights%252C%20Forecast%20to%202025

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.